Anti-HIV strategy

被引:0
作者
Wilson, E
机构
关键词
D O I
10.1021/cen-v084n014.p014a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:14 / 14
页数:1
相关论文
共 50 条
[31]   ANTI-HIV DRUG MECHANISM [J].
JONES, IM ;
JACOB, GS .
NATURE, 1991, 352 (6332) :198-198
[32]   TOWARDS ANTI-HIV VACCINES [J].
TYRRELL, DAJ .
VACCINE, 1988, 6 (03) :211-212
[33]   Anti-HIV Antibody Structure [J].
Hampton, Tracy .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21) :2315-2315
[34]   Anti-HIV design - Preface [J].
Parang, K .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (22)
[35]   ANTI-HIV ACTIVITY OF PROTOPORPHYRIN [J].
ASANAKA, M ;
KURIMURA, T ;
TOYA, H ;
OGAKI, J ;
KATO, Y .
AIDS, 1989, 3 (06) :403-404
[36]   Didanosine -: Videx® -: Anti-HIV [J].
不详 .
DRUGS OF THE FUTURE, 2001, 26 (06) :586-586
[37]   Anti-HIV natural products [J].
Singh, IP ;
Bharate, SB ;
Bhutani, KK .
CURRENT SCIENCE, 2005, 89 (02) :269-290
[38]   Anti-HIV triterpenoid components [J].
Han, Benyong ;
Peng, Zhenhua .
Journal of Chemical and Pharmaceutical Research, 2014, 6 (04) :438-443
[39]   Anonymous anti-HIV agent [J].
不详 .
NATURE MEDICINE, 1998, 4 (04) :371-371
[40]   Preventive anti-HIV vaccines [J].
Pialoux, G ;
Slama, L .
PRESSE MEDICALE, 2005, 34 (20) :1592-1596